In order to understand the complex mechanisms of tumorigenesis, detecting, interpreting, and exploiting different types of information from human cancer cells, is now a central focus for both basic researchers and drug development scientists. Our panel of experts will provide some insight into the progress being made, while highlighting the factors that have made it possible. They will discuss the imperative need to start out with the highest-quality cells and biological samples for research, to establish rigorous standards for sample and data collection and storage, and to develop a collaboration platform for the effective analysis and sharing of data obtained from disparate sources.
Jaspal Khillan, Ph.D., Research Associate Professor, Department of Microbiology & Molecular Genetics, University of Pittsburgh
Sophie Lelievre, DVM, LLM, PhD, Associate Professor, Department of Basic Medical Sciences and Associate Director, Discovery Groups, NCI-designated Purdue Center for Cancer Research, Purdue University
Lesley Mathews, Ph.D., Research Scientist, Biomolecular Screening and Profiling/Probe Development, National Institutes of Health (NIH)